A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Early Breast Cancer
Interventions: DRUG: monosialic gangliosides|OTHER: Placebo
Sponsor: Henan Cancer Hospital